China's huge vaccine manufacturing capacities are posing a major threat to India's dominance in the global vaccine market, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) warned.

PV Appaji, director general of Pharmexcil said on Wednesday that India would lose its supremacy in the global vaccine market unless the government comes forward to help the domestic vaccine makers.

With the news of receiving an approval from the US Food and Drug Administration for its anti-ulcer drug, the shares of Natco Pharma have hit a high by surging over 6 percent and reaching to Rs 498.90 on Wednesday.

Sun Pharmaceutical Industries, soon after agreeing to procure the U. S.-based URL Pharma's generic drugs business, has realized an upsurge in its shares.

Shares of Alexza Pharmaceuticals Inc. got increased by 10% when the company revealed that the European Union regulators have approved its drug Adasuve.

The company officials said the panel of European Union regulators has recommended allowing Adasuve for mild to moderate agitation taking place among patients suffering from schizophrenia or bipolar disorder.